Harbinger Group Inc.
    Print Page | Close Window

SEC Filings

10-K
HRG GROUP, INC. filed this Form 10-K on 11/23/2016
Entire Document
 << Previous Page | Next Page >>

HRG GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(In millions)
 
Common Stock
 
Additional Paid-in Capital
 
Accumulated Deficit
 
Accumulated Other Comprehensive Income
 
Total Shareholders’ Equity
 
Noncontrolling Interest (“NCI”)
 
Total Equity
 
Shares
 
Amount
 
 
 
 
 
 
Balances at September 30, 2013
142.4

 
$
1.4

 
$
828.0

 
$
(192.4
)
 
$
87.7

 
$
724.7

 
$
408.8

 
$
1,133.5

Net income

 

 

 
(10.3
)
 

 
(10.3
)
 
112.0

 
101.7

Unrealized investment gains, net

 

 

 

 
197.7

 
197.7

 
43.0

 
240.7

Other unrealized gains

 

 

 

 
6.8

 
6.8

 
4.7

 
11.5

Actuarial adjustments to pension plans

 

 

 

 
(4.0
)
 
(4.0
)
 
(1.7
)
 
(5.7
)
Translation adjustment

 

 

 

 
(19.1
)
 
(19.1
)
 
(13.4
)
 
(32.5
)
Comprehensive income
 
 
 
 
 
 
 
 
 
 
171.1

 
144.6

 
315.7

Repurchase of common stock
(5.2
)
 
(0.1
)
 
(65.5
)
 

 

 
(65.6
)
 

 
(65.6
)
Proceeds from public offering of subsidiary shares, net

 

 
(58.5
)
 

 
(25.5
)
 
(84.0
)
 
256.6

 
172.6

Purchases of subsidiary stock

 

 
(11.1
)
 

 

 
(11.1
)
 
2.8

 
(8.3
)
Exercise of stock options

 

 
2.8

 

 

 
2.8

 

 
2.8

Stock compensation
3.2

 
0.1

 
72.3

 

 

 
72.4

 
20.6

 
93.0

Restricted stock surrendered for tax withholding
(0.1
)
 

 
(21.1
)
 

 

 
(21.1
)
 
(10.4
)
 
(31.5
)
Preferred stock dividends, accretion and loss on conversion

 

 

 
(73.6
)
 

 
(73.6
)
 

 
(73.6
)
Conversion of preferred stock
62.0

 
0.6

 
725.4

 

 

 
726.0

 

 
726.0

NCI in acquired subsidiary

 

 

 

 

 

 
20.7

 
20.7

Dividend paid by subsidiary to NCI

 

 

 

 

 

 
(28.3
)
 
(28.3
)
Balances at September 30, 2014
202.3

 
2.0

 
1,472.3

 
(276.3
)
 
243.6

 
1,441.6

 
815.4

 
2,257.0

Net loss

 

 

 
(556.8
)
 

 
(556.8
)
 
44.4

 
(512.4
)
Unrealized investment losses, net

 

 

 

 
(206.1
)
 
(206.1
)
 
(50.5
)
 
(256.6
)
Other unrealized losses

 

 

 

 
(7.5
)
 
(7.5
)
 
(5.6
)
 
(13.1
)
Actuarial adjustments to pension plans

 

 

 

 
(7.0
)
 
(7.0
)
 
(4.7
)
 
(11.7
)
Translation adjustment

 

 

 

 
(65.7
)
 
(65.7
)
 
(47.2
)
 
(112.9
)
Comprehensive loss
 
 
 
 
 
 
 
 
 
 
(843.1
)
 
(63.6
)
 
(906.7
)
Repurchase of common stock
(1.7
)
 
(0.1
)
 
(22.1
)
 

 

 
(22.2
)
 

 
(22.2
)
Proceeds from public offering of subsidiary shares, net

 

 
29.9

 

 
1.3

 
31.2

 
249.8

 
281.0

Purchases of subsidiary stock

 

 
(76.8
)
 

 
0.7

 
(76.1
)
 
15.1

 
(61.0
)
Exercise of stock options
0.7

 

 
4.1

 

 

 
4.1

 

 
4.1

Stock compensation
1.4

 
0.1

 
71.0

 

 

 
71.1

 
18.9

 
90.0

Restricted stock surrendered for tax withholding
(1.3
)
 

 
(19.9
)
 

 

 
(19.9
)
 
(1.1
)
 
(21.0
)
NCI in acquired subsidiary

 

 

 

 

 

 
0.8

 
0.8

Dividend paid by subsidiary to NCI

 

 

 

 

 

 
(33.9
)
 
(33.9
)
Balances at September 30, 2015
201.4

 
2.0

 
1,458.5

 
(833.1
)
 
(40.7
)
 
586.7

 
1,001.4

 
1,588.1

Net loss

 

 

 
(198.8
)
 

 
(198.8
)
 
164.9

 
(33.9
)
Unrealized investment gains, net

 

 

 

 
279.3

 
279.3

 
68.6

 
347.9

Other unrealized gains

 

 

 

 
4.1

 
4.1

 
3.0

 
7.1

Actuarial adjustments to pension plans

 

 

 

 
(16.6
)
 
(16.6
)
 
(11.9
)
 
(28.5
)
Translation adjustment

 

 

 

 
(4.8
)
 
(4.8
)
 
(3.7
)
 
(8.5
)
Comprehensive income
 
 
 
 
 
 
 
 
 
 
63.2

 
220.9

 
284.1

Purchases of subsidiary stock

 

 
(34.6
)
 

 
(0.4
)
 
(35.0
)
 
(19.5
)
 
(54.5
)
Exercise of stock options
0.6

 

 
4.4

 

 

 
4.4

 

 
4.4

Stock compensation

 

 
42.9

 

 

 
42.9

 
21.4

 
64.3

Restricted stock surrendered for tax withholding
(1.2
)
 

 
(24.1
)
 

 

 
(24.1
)
 
(4.6
)
 
(28.7
)
NCI in acquired subsidiary

 

 

 

 

 

 

 

Dividend paid by subsidiary to NCI

 

 

 

 

 

 
(40.5
)
 
(40.5
)
Balances at September 30, 2016
200.8

 
$
2.0

 
$
1,447.1

 
$
(1,031.9
)
 
$
220.9

 
$
638.1

 
$
1,179.1

 
$
1,817.2

See accompanying notes to consolidated financial statements.

F-7

 << Previous Page | Next Page >>